There are few names more well-known in the biopharmaceutical world than bristol myers squibb and gilead sciences (nasdaq:gild

A month after the NIH declared the first trial on remdesivir in Covid-19 a success, Gilead is out with new results on their …

Coronavirus patients reportedly responding to Gilead's experimental treatment | Squawk Box EuropeIn an update, the european medicines agency’s advisory group chmp states that it has started a rolling review of data on‘ (nasdaq:gild) remdesivir for COVID-19. It finished the first c …

Jun 02, 2020 (iam newswire via COMTEX) — If COVID-19 has done something, it has made us realize that health should always be our top priority. No one …